Will NCT06506955 (Taiho Oncology, Inc.) still show a study completion date of 30 April 2027 or earlier when checked on 30 May 2027?
deadline 2027-05-30
confidence medium
tier 4 evidence
68%PolySignal estimate
Resolution criterion
Yes if, when NCT06506955 is read on clinicaltrials.gov on 30 May 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 30 April 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 2 October 2026: NCT06506955 is registered as ACTIVE_NOT_RECRUITING, sponsored by Taiho Oncology, Inc., with 15 participants. Started 2024-10; announced primary completion 2027-04-30, announced study completion 2027-04-30 — announced to the month only. Record last updated 2026-07-28. The date under test is 2027-04-30. Source: clinicaltrials.gov/study/NCT06506955
What pushes it up
- No change in the ClinicalTrials.gov record and the study remains ACTIVE_NOT_RECRUITING, indicating no known delay or termination [1]
What would move this number most
Whether the trial will experience a delay or termination before 30 May 2027.
How this number is built
| Deadline | 2027-05-30 |
| Base rate | 65% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 65 · 70 (spread 5 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-03 09:02 |
| Model | openai/gpt-oss-20b (Groq) |